The effects of modified ultrafiltration on pulmonary function and transfusion requirements in patients underwent coronary artery bypass graft surgery

被引:15
|
作者
Torina, Anali Galluce [1 ]
Petrucci, Orlando [1 ]
Martins de Oliveira, Pedro Paulo [1 ]
Barbosa de Oliveira Severino, Elaine Soraya [1 ]
de Souza Vilarinho, Karlos Alexandre [1 ]
Ramos Lavagnoli, Carlos Fernando [1 ]
Blotta, Maria Heloisa [1 ]
Vieira, Reinaldo Wilson [1 ]
机构
[1] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Cirurgia,Disciplina Cirurgia Cardiaca, Campinas, SP, Brazil
来源
关键词
Ultrafiltration; Coronary artery bypass; Myocardial revascularization; Hemorrhage; PEDIATRIC CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; CYTOKINES;
D O I
10.1590/S0102-76382010000100014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The inflammatory response after cardiac surgery increases vascular permeability leading to higher mortality and morbidity in the post operative time. The modified ultrafiltration (MUF) had shown benefits on respiratory, and hemodynamic in pediatric patients. This approach in adults is not well established yet. We hypothesize that modified ultrafiltration may improve respiratory, hemodynamic and coagulation function in adults after cardiac surgeries. Methods: A prospective randomized study was carried out with 37 patients who underwent coronary artery bypass graft surgery (CABG) were randomized either to MUF (n=20) at the end of bypass or to control (no MUF) (n=17). The anesthesia and ICU team were blinded for the group selection. The MUF were carried out for 15 minutes after the end of bypass. The patients data were taken at beginning of anesthesia, ending of bypass, ending MUF, 24 hours, and 48 hours after surgery. For clinical outcome the pulmonary, hemodynamic and coagulation function were evaluated. Results: We observed lower drain loss in the MUF group compared to control group after 48 hours (598 +/- 123 ml vs. 848 +/- 455 ml; P=0.04) and required less red blood cells units transfusion compared to control group (0.6 +/- 0.6 units/patient vs.1.6 +/- 1.1 units/patient; P=0.03). The MUF group showed lower airway resistance (9.3 +/- 0.4 cmH(2)O center dot L-1s-1 vs. 12.1 +/- 0.8 cmH(2)O center dot L-1s-1; P=0.04). There were no deaths in both groups. Conclusion: The MUF reduces post operatory bleeding and red blood cells units transfusion, but with no differences on clinical outcome were observed. The routinely MUF employment was not associated with hemodynamic instability.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [1] Transfusion requirements in clopidogrel-treated coronary artery bypass graft surgery patients.
    Radovancevic, R
    Chen, L
    Riggs, SA
    Nussmeier, NA
    Cooper, JR
    Bracey, AW
    TRANSFUSION, 2002, 42 (09) : 18S - 18S
  • [3] Blood loss from coronary angiography increases transfusion requirements for coronary artery bypass graft surgery
    Ereth, MH
    Nuttall, GA
    Orszulak, TA
    Santrach, PJ
    Cooney, WP
    Oliver, WC
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2000, 14 (02) : 177 - 181
  • [4] Symptoms and Care Satisfaction in Patients Who Underwent Coronary Artery Bypass Graft Surgery
    Bozkurt, Tugce
    Saglam, Rabia
    CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2021, 11 (03): : 481 - 486
  • [5] Clopidogrel and platelet transfusion in patients undergoing coronary artery bypass graft surgery
    Pivalizza, EG
    Warters, RD
    Gottschalk, LI
    Luehr, SL
    Hartwell, EA
    ANAESTHESIA, 2003, 58 (06) : 603 - 604
  • [6] Blood Transfusion After Coronary Artery Bypass Graft Surgery
    Dixon, Barry
    Santamaria, John D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02): : 149 - 150
  • [7] Pulmonary function 4 months after coronary artery bypass graft surgery
    Westerdahl, E
    Lindmark, B
    Bryngelsson, I
    Tenling, A
    RESPIRATORY MEDICINE, 2003, 97 (04) : 317 - 322
  • [8] Clopidogrel on bleeding and transfusion requirements after coronary bypass graft surgery
    Tanaka, KA
    Tsuda, A
    Szlam, F
    Olson, PJ
    Levy, JH
    ANESTHESIOLOGY, 2000, 93 (3A) : U147 - U147
  • [9] REGIONAL VARIATION IN ANGIOGRAM USE FOR PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFT SURGERY
    Baser, O.
    Burkan, A.
    Baser, E.
    Koselerli, R.
    Ertugay, E.
    Altinbas, A.
    VALUE IN HEALTH, 2012, 15 (07) : A402 - A402
  • [10] Blood Transfusion After Coronary Artery Bypass Graft Surgery Reply
    Bennett-Guerrero, Elliott
    Ferguson, T. B., Jr.
    Song, Howard K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (02): : 150 - 150